Registered Malawi · PMRA

CARDINOL 10MG TABLET

LISNOPRIL

PMPB/PL513/1 TABLET

What it does

Lisinopril is a medication used to manage blood pressure and heart failure. It helps to relax blood vessels, making it easier for the heart to pump blood.

Commonly used for: high blood pressure (hypertension), heart failure

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL513/1
Registration date
12/06/2019
Expiry date
31/03/2025
Status
Registered
Active ingredient
LISNOPRIL
Dosage form
TABLET
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:45 · updated 2026-09-29 04:33:06

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Lisinopril is a medication used to manage blood pressure and heart failure. It helps to relax blood vessels, making it easier for the heart to pump blood.

What it treats

  • high blood pressure (hypertension)
  • heart failure

How it works

Lisinopril helps to relax blood vessels, which lowers blood pressure and improves blood flow.

Who it's for

This medication is suitable for adults with high blood pressure or heart failure.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: lisnopril

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily in the treatment of hypertension, heart failure, and to improve survival after myocardial infarction. It works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, leading to vasodilation and reduced blood pressure.

Indications

  • Hypertension
  • Heart failure
  • Myocardial infarction
  • Diabetic nephropathy
  • Chronic kidney disease

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing recommendations.

Adults: Refer to the BNF for specific adult dosing recommendations based on the condition being treated.

Mechanism of action

Lisinopril inhibits the ACE enzyme, which converts angiotensin I to angiotensin II. By blocking this conversion, lisinopril decreases levels of angiotensin II, resulting in less vasoconstriction and lower blood pressure. It also reduces aldosterone secretion, leading to decreased sodium and water retention.

Pharmacodynamics

The pharmacodynamic effects of lisinopril include decreased peripheral vascular resistance, reduced preload and afterload on the heart, and improved exercise tolerance in patients with heart failure. It can also help to reduce the risk of cardiovascular events in patients with hypertension and other cardiovascular risk factors.

Pharmacokinetics

Lisinopril is well absorbed from the gastrointestinal tract, with a bioavailability of approximately 25%. It is not significantly protein-bound and is primarily eliminated by the kidneys. The half-life of lisinopril is approximately 12 hours, allowing for once-daily dosing. Peak plasma concentrations occur about 7 hours after oral administration.

Contra-indications

  • Hypersensitivity to lisinopril or any component of the formulation
  • History of angioedema related to previous ACE inhibitor therapy
  • Pregnancy
  • Severe renal impairment or renal artery stenosis

Adverse effects

  • Cough
  • Hyperkalemia
  • Hypotension
  • Dizziness
  • Fatigue
  • Angioedema
  • Rash
  • Renal impairment
  • Nausea

Interactions

  • Potassium-sparing diuretics may increase the risk of hyperkalemia
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect
  • Lithium levels may increase, requiring monitoring
  • Other antihypertensive agents may have additive effects

Precautions

  • Monitor renal function and electrolytes periodically
  • Use with caution in patients with a history of angioedema
  • Caution in patients with heart failure or volume depletion
  • Careful monitoring is needed in elderly patients or those with comorbidities

Pregnancy

Lisinopril is contraindicated during pregnancy due to potential harm to the fetus, especially during the second and third trimesters.

Breast-feeding

Lisinopril is excreted in breast milk; caution is advised when administered to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Tablets
  • Oral solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.